• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT TOTAL PSA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT TOTAL PSA Back to Search Results
Catalog Number 07K70-30
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/28/2016
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 7k70 that has a similar product distributed in the us, list number 6c06.
 
Event Description
The customer stated that the architect analyzer generated falsely decreased total psa results on one patient.The results provided were: (b)(6) 2016 = 4.09 ng/ml / repeated same day = 0.867 / on (b)(6) 2016 two additional tubes from the same patient = 3.706 / 3.582 ng/ml.There was no reported impact to patient management.There was no additional patient information provided.
 
Manufacturer Narrative
The customer reported a single depressed total psa result for one patient when tested using architect total psa, list 7k70-30, lot 66173fn00.A review of tickets determined that there is no unusual activity for lot 66173fn00 and no trends for this issue.No patient sample was available to assist in the investigation.Accuracy testing of a serum based panel, which mimics a patient sample and with a target concentration of 3.86 ng/ml, was performed using a retained kit of lot 66173fn00.All specifications were met indicating that lot 66173fn00 is performing acceptably.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of product labeling shows adequate information to troubleshoot the falsely decreased patient result.Based on all available information and this investigation, the assay performed as intended and no product deficiency was identified.
 
Manufacturer Narrative
The device evaluation was reassessed and concluded that a malfunction occurred, therefore the device was not performing as intended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT TOTAL PSA
Type of Device
TOTAL PSA
Manufacturer (Section D)
ABBOTT IRELAND
diagnostics division
finisklin business park
sligo NA
EI  NA
Manufacturer (Section G)
ABBOTT IRELAND
diagnostics division
finisklin business park
sligo NA
EI   NA
Manufacturer Contact
noemi romero-kondos, rn bsn
100 abbott park road
dept. 09b9, lccp1-3
abbott park, IL 60064-3537
224667-512
MDR Report Key6192967
MDR Text Key62964316
Report Number3008344661-2016-00077
Device Sequence Number1
Product Code LTJ
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
P910007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 05/26/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/27/2017
Device Catalogue Number07K70-30
Device Lot Number66173FN00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/01/2016
Initial Date FDA Received12/21/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received01/31/2017
05/26/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/01/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Treatment
SERIAL # (B)(4)
-
-